{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:48:07Z","timestamp":1782463687109,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T00:00:00Z","timestamp":1332892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T00:00:00Z","timestamp":1332892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep00341","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T13:10:00Z","timestamp":1332940200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp"],"prefix":"10.1038","volume":"2","author":[{"given":"David M.","family":"Vu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Pajon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Reason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan M.","family":"Granoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,28]]},"reference":[{"key":"BFsrep00341_CR1","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1086\/648966","volume":"50 Suppl 2","author":"DM Granoff","year":"2010","unstructured":"Granoff, D. M. Review of meningococcal group B vaccines. Clin. Infect. Dis. 50 Suppl 2, S54\u201365 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep00341_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1473-3099(09)70324-X","volume":"10","author":"M Sadarangani","year":"2010","unstructured":"Sadarangani, M. & Pollard, A. J. Serogroup B meningococcal vaccines-an unfinished story. Lancet Infect. Dis. 10, 112\u2013124 (2010).","journal-title":"Lancet Infect. Dis."},{"key":"BFsrep00341_CR3","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1073\/pnas.0603940103","volume":"103","author":"MM Giuliani","year":"2006","unstructured":"Giuliani, M. M. et al. A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. U. S. A. 103, 10834\u201310839 (2006).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep00341_CR4","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.vaccine.2010.12.075","volume":"29","author":"DM Vu","year":"2011","unstructured":"Vu, D. M., Wong, T. T. & Granoff, D. M. Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen. Vaccine. 29, 1968\u20131973 (2011).","journal-title":"Vaccine."},{"key":"BFsrep00341_CR5","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1097\/INF.0b013e3181faa6be","volume":"29","author":"MD Snape","year":"2010","unstructured":"Snape, M. D. et al. Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial. Pediatr. Infect. Dis. J. 29, e71\u201379 (2010).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFsrep00341_CR6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1086\/656741","volume":"51","author":"J Findlow","year":"2010","unstructured":"Findlow, J. et al. Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin. Infect. Dis. 51, 1127\u20131137 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"BFsrep00341_CR7","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","volume":"72","author":"LD Fletcher","year":"2004","unstructured":"Fletcher, L. D. et al. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect. Immun. 72, 2088\u20132100 (2004).","journal-title":"Infect. Immun."},{"key":"BFsrep00341_CR8","doi-asserted-by":"publisher","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","volume":"27 Suppl 2","author":"CE Frasch","year":"2009","unstructured":"Frasch, C. E., Borrow, R. & Donnelly, J. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. Vaccine. 27 Suppl 2, B112\u2013116 (2009).","journal-title":"Vaccine."},{"key":"BFsrep00341_CR9","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","volume":"23","author":"R Borrow","year":"2005","unstructured":"Borrow, R., Balmer, P. & Miller, E. Meningococcal surrogates of protection--serum bactericidal antibody activity. Vaccine. 23, 2222\u20132227 (2005).","journal-title":"Vaccine."},{"key":"BFsrep00341_CR10","doi-asserted-by":"publisher","first-page":"B117","DOI":"10.1016\/j.vaccine.2009.04.066","volume":"27 Suppl 2","author":"DM Granoff","year":"2009","unstructured":"Granoff, D. M. Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease. Vaccine. 27 Suppl 2, B117\u2013125 (2009).","journal-title":"Vaccine."},{"key":"BFsrep00341_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1086\/600141","volume":"200","author":"E Murphy","year":"2009","unstructured":"Murphy, E. et al. Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J. Infect. Dis. 200, 379\u2013389 (2009).","journal-title":"J. Infect. Dis."},{"key":"BFsrep00341_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1084\/jem.20021911","volume":"197","author":"V Masignani","year":"2003","unstructured":"Masignani, V. et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J. Exp. Med. 197, 789\u2013799 (2003).","journal-title":"J. Exp. Med."},{"key":"BFsrep00341_CR13","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1099\/mic.0.029876-0","volume":"155","author":"PT Beernink","year":"2009","unstructured":"Beernink, P. T. & Granoff, D. M. The modular architecture of meningococcal factor H-binding protein. Microbiology. 155, 2873\u20132883 (2009).","journal-title":"Microbiology."},{"key":"BFsrep00341_CR14","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1128\/IAI.00033-08","volume":"76","author":"PT Beernink","year":"2008","unstructured":"Beernink, P. T. & Granoff, D. M. Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines. Infect. Immun. 76, 2568\u20132575 (2008).","journal-title":"Infect. Immun."},{"key":"BFsrep00341_CR15","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","volume":"172","author":"JA Welsch","year":"2004","unstructured":"Welsch, J. A., Rossi, R., Comanducci, M. & Granoff, D. M. Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine. J. Immunol. 172, 5606\u20135615 (2004).","journal-title":"J. Immunol."},{"key":"BFsrep00341_CR16","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1128\/IAI.00367-08","volume":"76","author":"PT Beernink","year":"2008","unstructured":"Beernink, P. T. et al. Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate, factor H-binding protein. Infect. Immun. 76, 4232\u20134240 (2008).","journal-title":"Infect. Immun."},{"key":"BFsrep00341_CR17","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.4049\/jimmunol.1003470","volume":"186","author":"PT Beernink","year":"2011","unstructured":"Beernink, P. T. et al. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination. J. Immunol. 186, 3606\u20133614 (2011).","journal-title":"J. Immunol."},{"key":"BFsrep00341_CR18","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.vaccine.2009.12.027","volume":"28","author":"R Pajon","year":"2010","unstructured":"Pajon, R., Beernink, P. T., Harrison, L. H. & Granoff, D. M. Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates. Vaccine. 28, 2122\u20132129 (2010).","journal-title":"Vaccine."},{"key":"BFsrep00341_CR19","doi-asserted-by":"publisher","first-page":"e1302","DOI":"10.1371\/journal.pntd.0001302","volume":"5","author":"R Pajon","year":"2011","unstructured":"Pajon, R., Fergus, A. M., Koeberling, O., Caugant, D. A. & Granoff, D. M. Meningococcal factor H binding proteins in epidemic strains from Africa: Implications for vaccine development. PLoS Negl. Trop. Dis. 5, e1302 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFsrep00341_CR20","doi-asserted-by":"publisher","first-page":"19490","DOI":"10.1073\/pnas.1013758107","volume":"107","author":"J Donnelly","year":"2010","unstructured":"Donnelly, J. et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc. Natl. Acad. Sci. U. S. A. 107, 19490\u201319495 (2010).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep00341_CR21","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","volume":"28","author":"HQ Jiang","year":"2010","unstructured":"Jiang, H. Q. et al. Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine. 28, 6086\u20136093 (2010).","journal-title":"Vaccine."},{"key":"BFsrep00341_CR22","doi-asserted-by":"publisher","first-page":"91ra62","DOI":"10.1126\/scitranslmed.3002234","volume":"3","author":"M Scarselli","year":"2011","unstructured":"Scarselli, M. et al. Rational design of a meningococcal antigen inducing broad protective immunity. Sci. Transl. Med. 3, 91ra62 (2011).","journal-title":"Sci. Transl. Med."},{"key":"BFsrep00341_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/molbev\/msj030","volume":"23","author":"DH Huson","year":"2006","unstructured":"Huson, D. H. & Bryant, D. Application of phylogenetic networks in evolutionary studies. Mol. Biol. Evol. 23, 254\u2013267 (2006).","journal-title":"Mol. Biol. Evol."},{"key":"BFsrep00341_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1086\/528994","volume":"197","author":"JA Welsch","year":"2008","unstructured":"Welsch, J. A., Ram, S., Koeberling, O. & Granoff, D. M. Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen. J. Infect. Dis. 197, 1053\u20131061 (2008).","journal-title":"J. Infect. Dis."},{"key":"BFsrep00341_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","volume":"177","author":"G Madico","year":"2006","unstructured":"Madico, G. et al. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J. Immunol. 177, 501\u2013510 (2006).","journal-title":"J. Immunol."},{"key":"BFsrep00341_CR26","doi-asserted-by":"publisher","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","volume":"176","author":"MC Schneider","year":"2006","unstructured":"Schneider, M. C. et al. Functional significance of factor H binding to Neisseria meningitidis. J. Immunol. 176, 7566\u20137575 (2006).","journal-title":"J. Immunol."},{"key":"BFsrep00341_CR27","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1128\/IAI.01191-08","volume":"77","author":"DM Granoff","year":"2009","unstructured":"Granoff, D. M., Welsch, J. A. & Ram, S. Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect. Immun. 77, 764\u2013769 (2009).","journal-title":"Infect. Immun."},{"key":"BFsrep00341_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1128\/IAI.05604-11","volume":"80","author":"DM Vu","year":"2012","unstructured":"Vu, D. M. et al. Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis. Infect. Immun. 80, 643\u2013650 (2012).","journal-title":"Infect. Immun."},{"key":"BFsrep00341_CR29","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.molimm.2009.02.021","volume":"46","author":"PT Beernink","year":"2009","unstructured":"Beernink, P. T., Lopasso, C., Angiolillo, A., Felici, F. & Granoff, D. A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups. Mol. Immunol. 46, 1647\u20131653 (2009).","journal-title":"Mol. Immunol."},{"key":"BFsrep00341_CR30","doi-asserted-by":"crossref","unstructured":"Giuntini, S., Beernink, P. T., Reason, D. C. & Granoff, D. M. Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity. PloS One, In press (2012).","DOI":"10.1371\/journal.pone.0034272"},{"key":"BFsrep00341_CR31","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1128\/IAI.73.2.1151-1160.2005","volume":"73","author":"MM Giuliani","year":"2005","unstructured":"Giuliani, M. M. et al. The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies. Infect. Immun. 73, 1151\u20131160 (2005).","journal-title":"Infect. Immun."},{"key":"BFsrep00341_CR32","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1016\/j.vaccine.2009.01.075","volume":"27","author":"LK McNeil","year":"2009","unstructured":"McNeil, L. K. et al. Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide. Vaccine. 27, 3417\u20133421 (2009).","journal-title":"Vaccine."},{"key":"BFsrep00341_CR33","doi-asserted-by":"publisher","first-page":"9022","DOI":"10.1074\/jbc.C800214200","volume":"284","author":"F Cantini","year":"2009","unstructured":"Cantini, F. et al. Solution structure of the factor H-binding protein, a survival factor and protective antigen of Neisseria meningitidis. J. Biol. Chem. 284, 9022\u20139026 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFsrep00341_CR34","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.1074\/jbc.M808831200","volume":"284","author":"A Mascioni","year":"2009","unstructured":"Mascioni, A. et al. Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086. J. Biol. Chem. 284, 8738\u20138746 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFsrep00341_CR35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature07769","volume":"458","author":"MC Schneider","year":"2009","unstructured":"Schneider, M. C. et al. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. .Nature 458, 890\u2013893 (2009).","journal-title":"Nature"},{"key":"BFsrep00341_CR36","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1128\/IAI.05182-11","volume":"79","author":"S Giuntini","year":"2011","unstructured":"Giuntini, S., Reason, D. C. & Granoff, D. M. Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding. Infect. Immun. 79, 3751\u20133759 (2011).","journal-title":"Infect. Immun."},{"key":"BFsrep00341_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jmb.2008.12.005","volume":"386","author":"M Scarselli","year":"2009","unstructured":"Scarselli, M. et al. Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis. J. Mol. Biol. 386, 97\u2013108 (2009).","journal-title":"J. Mol. Biol."},{"key":"BFsrep00341_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00216-005-0065-y","volume":"384","author":"J Gasteiger","year":"2006","unstructured":"Gasteiger, J. Chemoinformatics: a new field with a long tradition. Anal. Bioanal. Chem. 384, 57\u201364 (2006).","journal-title":"Anal. Bioanal. Chem."},{"key":"BFsrep00341_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jmb.2004.07.053","volume":"342","author":"G Chao","year":"2004","unstructured":"Chao, G., Cochran, J. R. & Wittrup, K. D. Fine epitope mapping of anti-epidermal growth factor receptor antibodies through random mutagenesis and yeast surface display. J. Mol. Biol. 342, 539\u2013550 (2004).","journal-title":"J. Mol. Biol."},{"key":"BFsrep00341_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nbt0697-553","volume":"15","author":"ET Boder","year":"1997","unstructured":"Boder, E. T. & Wittrup, K. D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15, 553\u2013557 (1997).","journal-title":"Nat. Biotechnol."},{"key":"BFsrep00341_CR41","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.4049\/jimmunol.160.10.5028","volume":"160","author":"DM Granoff","year":"1998","unstructured":"Granoff, D. M. et al. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid. J. Immunol. 160, 5028\u20135036 (1998).","journal-title":"J. Immunol."},{"key":"BFsrep00341_CR42","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1086\/514821","volume":"195","author":"PT Beernink","year":"2007","unstructured":"Beernink, P. T. et al. Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine. J. Infect. Dis. 195, 1472\u20131479 (2007).","journal-title":"J. Infect. Dis."}],"updated-by":[{"DOI":"10.1038\/srep01499","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T00:00:00Z","timestamp":1363737600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep00341","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:35:25Z","timestamp":1672979725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep00341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,28]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,12,21]]}},"alternative-id":["BFsrep00341"],"URL":"https:\/\/doi.org\/10.1038\/srep00341","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,28]]},"assertion":[{"value":"11 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2013","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.M.G. holds a paid consultancy with Novartis Vaccines and Diagnostics. D.M.G. R.P. and D.M.V. are inventors on patents or patent applications in the area of meningococcal B vaccines. D.C.R. report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}